ATNM
Actinium Pharmaceuticals Inc
Description:
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation (BMT) or a type of cell therapy, and for other adoptive cell therapies. The company is headquartered in New York, New York.
Address:
100 PARK AVENUE, NEW YORK, NY, UNITED STATES, 10017
Fiscal year end:
December
Market capitalization:
$33.9 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-98%
How much will you get:
$22
Prices dates:
31-05-2016: $57.90 and 29-05-2026: $1.26